Literature DB >> 19948160

Single immunoglobulin IL-1 receptor-related protein attenuates the lipopolysaccharide-induced inflammatory response in A549 cells.

Tian Feng1, Ni Yunfeng, Zhao Jinbo, Zhang Zhipei, Zhang Huizhong, Liu Li, Jiang Tao, Wang Yunjie.   

Abstract

The lipopolysaccharide (LPS)-Toll-like receptor 4 (TLR4) signaling pathway in alveolar epithelial cells plays an important role in many pathologic processes such as acute lung injury (ALI). The single immunoglobulin IL-1 receptor-related protein (SIGIRR) is an inhibitor of LPS-TLR4 signaling, but its expression and function in alveolar epithelial cells are still unknown. In this study, we examined the expression of SIGIRR in normal human lung tissue using immunohistochemistry, reverse transcription-PCR (RT-PCR) and Western blot and found that SIGIRR was expressed in alveolar epithelial cells. Treatment of an alveolar epithelial cell line, A549, with LPS and we observed a downregulation of SIGIRR mRNA, which returned to normal levels 24h after LPS exposure. A549 cells were then transfected with a SIGIRR eukaryotic expression vector to over-express SIGIRR or, as a control, with an empty vector. Following LPS exposure, the transcriptional activity of NF-kappaB was measured using a dual-luciferase reporter assay system, and the concentration of IL-1beta, TNF-alpha and IL-6 was determined by ELISA, and cell proliferation was measured by MTT. In A549 cells that over-expressed SIGIRR, LPS treatment resulted in a significant decrease in the transcriptional activity of NF-kappaB and cell growth inhibition ratio, as well as lower levels of secreted IL-1beta, TNF-alpha and IL-6. In conclusion, SIGIRR in A549 cells inhibits the transcriptional activity of NF-kappaB and reduces the amount cytokines produced, protecting these cells from acute LPS-induced damage. Copyright (c) 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19948160     DOI: 10.1016/j.cbi.2009.11.022

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  6 in total

1.  Depletion of Alveolar Macrophages Increases Pulmonary Neutrophil Infiltration, Tissue Damage, and Sepsis in a Murine Model of Acinetobacter baumannii Pneumonia.

Authors:  Hiu Ham Lee; Lilit Aslanyan; Arjun Vidyasagar; Melissa B Brennan; Maxine S Tauber; Maria A Carrillo-Sepulveda; Michael R Dores; Nathan W Rigel; Luis R Martinez
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

2.  The toll interleukin-1 receptor (IL-1R) 8/single Ig domain IL-1R-related molecule modulates the renal response to bacterial infection.

Authors:  Jaklien C Leemans; Loes M Butter; Gwendoline J D Teske; Ingrid Stroo; Wilco P Pulskens; Sandrine Florquin
Journal:  Infect Immun       Date:  2012-08-13       Impact factor: 3.441

3.  Endotoxin-induced lung alveolar cell injury causes brain cell damage.

Authors:  Raquel Rodríguez-González; Ángela Ramos-Nuez; José Luis Martín-Barrasa; Josefina López-Aguilar; Aurora Baluja; Julián Álvarez; Patricia R M Rocco; Paolo Pelosi; Jesús Villar
Journal:  Exp Biol Med (Maywood)       Date:  2014-08-18

4.  Rosiglitazone alleviates lipopolysaccharide-induced inflammation in RAW264.7 cells via inhibition of NF-κB and in a PPARγ-dependent manner.

Authors:  Jing-Ping Zhou; Xiao-Ning Yang; Yang Song; Fei Zhou; Jing-Jing Liu; Yi-Qun Hu; Li-Gang Chen
Journal:  Exp Ther Med       Date:  2021-05-11       Impact factor: 2.447

5.  Regulatory mechanism of NOV/CCN3 in the inflammation and apoptosis of lung epithelial alveolar cells upon lipopolysaccharide stimulation.

Authors:  Hai-Ping Zhu; Hui-Ya Huang; Deng-Min Wu; Nian Dong; Li Dong; Cheng-Shui Chen; Chao-Lei Chen; Yu-Guo Chen
Journal:  Mol Med Rep       Date:  2019-09-09       Impact factor: 2.952

6.  Negative Effects of SIGIRR on TRAF6 Ubiquitination in Acute Lung Injury In Vitro.

Authors:  Feng Tian; Qiang Lu; Jie Lei; Yunfeng Ni; Nianlin Xie; Daixing Zhong; Guang Yang; Shaokui Si; Tao Jiang
Journal:  J Immunol Res       Date:  2020-10-15       Impact factor: 4.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.